Hua Medicine (Shanghai) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,092	1,140	1,461	490.63	675.24
Cash & Short-Term Investments	1,092	1,140	1,461	490.63	675.24
Cash Growth	-4.16%	-21.98%	197.74%	-27.34%	-34.58%
Accounts Receivable	74.83	34.39	0.98	12.94	-
Other Receivables	4.78	22.18	15.81	408.96	9.7
Receivables	79.61	56.57	16.79	421.9	9.7
Inventory	121.85	126.7	67.87	18.46	-
Prepaid Expenses	1.45	-	-	-	-
Other Current Assets	1.24	13.48	27	9.27	19.66
Total Current Assets	1,296	1,336	1,572	940.26	704.6
Property, Plant & Equipment	110.07	129.66	114.54	139.71	156.6
Other Intangible Assets	22.59	26.07	28.57	31.95	9.03
Other Long-Term Assets	40.65	35.07	9.79	9.58	33.33
Total Assets	1,470	1,527	1,725	1,121	903.55
Accounts Payable	81.65	63.72	51.63	20.98	23.79
Accrued Expenses	60.38	37.9	37.17	38.37	32.15
Short-Term Debt	-	-	-	33.92	-
Current Portion of Long-Term Debt	30.61	98.28	17.19	-	-
Current Portion of Leases	18.05	17.26	24.28	21.49	13.3
Current Unearned Revenue	-	98.04	98.38	53.86	13.85
Other Current Liabilities	19.58	15.07	23.38	19.76	23.8
Total Current Liabilities	210.27	330.27	252.03	188.39	106.88
Long-Term Debt	220.56	138.74	106.84	-	-
Long-Term Leases	32.46	45.91	19.44	42.17	58.23
Long-Term Unearned Revenue	-	1,148	1,246	611.36	288.11
Total Liabilities	463.28	1,663	1,624	841.92	453.22
Common Stock	7.22	7.21	7.21	7.21	7.21
Additional Paid-In Capital	-	5,932	5,931	5,922	5,910
Retained Earnings	-	-6,361	-6,111	-5,900	-5,696
Treasury Stock	-0.41	-0.49	-0.51	-0.58	-0.63
Comprehensive Income & Other	999.64	286.43	274.5	250.96	229.63
Total Common Equity	1,006	-135.47	101.15	279.58	450.33
Shareholders' Equity	1,006	-135.47	101.15	279.58	450.33
Total Liabilities & Equity	1,470	1,527	1,725	1,121	903.55
Total Debt	301.67	300.18	167.75	97.58	71.53
Net Cash (Debt)	790.62	839.57	1,293	393.05	603.71
Net Cash Growth	-5.83%	-35.07%	228.98%	-34.89%	-36.54%
Net Cash Per Share	0.79	0.86	1.32	0.41	0.63
Filing Date Shares Outstanding	991.23	983.66	980.52	970.11	963.55
Total Common Shares Outstanding	991.23	983.66	980.52	970.11	963.55
Working Capital	1,086	1,006	1,320	751.87	597.72
Book Value Per Share	1.02	-0.14	0.10	0.29	0.47
Tangible Book Value	983.86	-161.53	72.58	247.63	441.31
Tangible Book Value Per Share	0.99	-0.16	0.07	0.26	0.46
Machinery	-	27.33	25.49	23.46	21.61
Construction In Progress	-	24.54	22.4	21.3	18.92
Leasehold Improvements	-	44.15	43.88	43.33	40.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.